![Daniel W. Elger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel W. Elger
Keine laufenden Positionen mehr
Karriereverlauf von Daniel W. Elger
Ehemalige bekannte Positionen von Daniel W. Elger
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
E-THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 13.06.2011 | 07.04.2014 |
Finanzdirektor/CFO | 14.06.2011 | 07.04.2014 | |
Investor Relations Kontakt | 13.06.2011 | 07.04.2014 | |
Sarossa Capital Ltd.
![]() Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Public Communications Contact | 01.01.2002 | - |
Vertrieb & Marketing | 01.01.2002 | - | |
Summit Therapeutics Ltd.
![]() Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Avenue Healthcare Knowledge Management Ltd.
![]() Avenue Healthcare Knowledge Management Ltd. Miscellaneous Commercial ServicesCommercial Services Avenue Healthcare Knowledge Management Ltd. provides public relations and communication consulting services to the healthcare sector. The company was founded on September 30, 1997 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
Calliditas Therapeutics Suisse SA
![]() Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Finanzdirektor/CFO | - | - |
Ausbildung von Daniel W. Elger
University of Oxford | Doctorate Degree |
Statistik
International
Vereinigtes Königreich | 6 |
Schweiz | 2 |
Operativ
Director of Finance/CFO | 2 |
Public Communications Contact | 1 |
Sales & Marketing | 1 |
Sektoral
Health Technology | 4 |
Finance | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
E-THERAPEUTICS PLC | Health Technology |
Private Unternehmen | 4 |
---|---|
Sarossa Capital Ltd.
![]() Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Finance |
Calliditas Therapeutics Suisse SA
![]() Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
Avenue Healthcare Knowledge Management Ltd.
![]() Avenue Healthcare Knowledge Management Ltd. Miscellaneous Commercial ServicesCommercial Services Avenue Healthcare Knowledge Management Ltd. provides public relations and communication consulting services to the healthcare sector. The company was founded on September 30, 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
Summit Therapeutics Ltd.
![]() Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Daniel W. Elger
- Erfahrung